Diagnostic Evidence Co-operative Newcastle
The Diagnostic Evidence Co-operative Newcastle is a partnership between Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University.
The NIHR DEC Newcastle facilitates the generation of high quality evidence on clinical validity, utility and cost-effectiveness of in vitro diagnostic medical devices (IVDs) for use in the NHS.
For more information see About us
News & Developments
NEW! - PhD Studentship in Diagnostic Test Evaluation Methodology - Evaluations of diagnostic tests in the presence of an imperfect reference standard and the health economic considerations
An exciting opportunity for a PhD student to be at the forefront of diagnostic test methodology research. It will explore how to improve estimates of diagnostic accuracy and removal of bias. It will then use value of information (VOI) analysis to estimate if the benefits of that research outweighs the time and cost required to carry out that research of that research. For details and to apply click here
13th Call for NIHR i4i Product Development Awards
NIHR i4i Product Development awards support research and development of medical devices, active implantable devices and in vitro diagnostic devices in any area of existing or emerging clinical need. These awards comprise both early and late stages of research and development, including the clinical development of laboratory-validated technologies or interventions. Click here for details
£10 million Biomedical Catalyst 2016 competition now open
A new funding boost of £57.5 million was announced for the UK’s energy and infrastructure, biomedical and quantum technology sectors by Business Secretary Sajid Javid at the first inter-ministerial group on business engagement. Click here for details of the competition and how to apply.
£15m Stratified Medicine Initiative - call for proposals for disease-focused partnerships to stratify for patient benefit
This call aims to support consortia to address disease areas where there is a strong case for scientific advancement and major unmet clinical need. The call will maintain stratification by response to treatment but broaden the scope to include stratification by risk, diagnosis and/or prognosis. Up to £15m to fund consortia up to 5 years in duration will be available. Click here for details of the competition and how to apply.
Postgraduate on-line learning programme in:
Clinical Health Sciences Molecular Pathology